



March 16, 2024 10:00
March 16, 2024 09:50 Victor Gonzalez
Lymphoma Research Foundation
March 16, 2024 10:00 Manali Kamdar, MD
University of Colorado
March 16, 2024 10:00 Paolo Strati, MD
MD Anderson Cancer Center
March 16, 2024 10:00 Kara Kelly, MD
University of Buffalo
March 16, 2024 11:15
March 16, 2024 11:15 Jennifer Amengual, MD
Columbia University Medical Center
This session is sponsored by Abbvie, Genentech, Genmab, and Kite, A Gileady Company.
March 16, 2024 11:15 Mazie Tsang, MD
Mayo Clinic, Arizona
This session is sponsored by AstraZeneca, Bristol-Myers Squibb, Genentech, and Pharmacyclics and Janssen.
March 16, 2024 11:15 Laurie Sehn, MD
British Columbia Cancer Agency
This session is sponsored by Abbvie, Bristol-Myers Squibb, Genmab, and Kite, A Gilead, Company.
March 16, 2024 11:15 Reid Merryman, MD
Dana-Farber Cancer Institute
March 16, 2024 11:15 David Bond, MD
Ohio State University
March 16, 2024 11:15 Luis Malpica Castillo, MD
MD Anderson Cancer Center
March 16, 2024 11:15 Prashant Kapoor, MD
Mayo Clinic, Rochester
This session is sponsored by Pharmacyclics and Janssen.
March 16, 2024 11:15 Raphael Steiner, MD
Memorial Sloan Kettering Cancer Center
EBV-positive diffuse large B-cell lymphoma (EBV+DLBCL)
Hepatosplenic T-cell lymphoma
Enteropathy-associated T-cell lymphoma
March 16, 2024 12:30
March 16, 2024 12:30 Peter Adintori, MS, RD, CSO, CDN, CNSC
Memorial Sloan Kettering Cancer Center
March 16, 2024 12:30 Santhosshi Narayanan, MD, FACP
MD Anderson Cancer Center










